<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <title>Extracted Document</title>
    <style>
        body { font-family: Arial, sans-serif; max-width: 900px; margin: 0 auto; padding: 20px; }
        h1, h2, h3 { color: #333; }
        .page { margin-bottom: 50px; border-bottom: 2px solid #ccc; padding-bottom: 30px; }
        .title { font-size: 1.3em; font-weight: bold; margin: 20px 0; }
        .text { margin: 15px 0; line-height: 1.6; }
        .figure { margin: 20px 0; text-align: center; }
        .figure img { max-width: 100%; height: auto; border: 1px solid #ddd; }
        .figure-caption { font-style: italic; color: #666; margin-top: 10px; }
        .metadata { background: #f5f5f5; padding: 15px; margin-top: 30px; }
    </style>
</head>
<body>

<h1>Extracted Document</h1>
<p><strong>Source:</strong> data/clinical_files/CDC Influenza vaccines.pdf</p>
<p><strong>Total Pages:</strong> 2</p>
<hr>
<div class="page">
<h2>Page 1</h2>
<div class="title">Flu zone Quad rival ent (San of i Pasteur) 0.5-mL PFS†† ≥6 mos†† 15 µg/0.5 mL IM — 0.5-mL SDV†† ≥6 mos†† 15 µg/0.5 mL IM — 5 0-mL MDV†† ≥6 mos†† 7 5 µg/0 25 mL IM 25 ¶ ¶ ¶</div>
<div class="figure">
<img src="figures/figure_p1_a9982f2b.png" alt="[FIGURE 2 - See figure_p1_a9982f2b.png]" style="max-width: 800px;">
<div class="figure-caption">[FIGURE 2 - See figure_p1_a9982f2b.png]</div>
</div>
<div class="figure">
<img src="figures/figure_p1_e6cdee9e.png" alt="[FIGURE 4 - See figure_p1_e6cdee9e.png]" style="max-width: 800px;">
<div class="figure-caption">[FIGURE 4 - See figure_p1_e6cdee9e.png]</div>
</div>
</div>
<div class="page">
<h2>Page 2</h2>
<div class="figure">
<img src="figures/figure_p2_a0da6ab5.png" alt="[FIGURE 1 - See figure_p2_a0da6ab5.png]" style="max-width: 800px;">
<div class="figure-caption">[FIGURE 1 - See figure_p2_a0da6ab5.png]</div>
</div>
<div class="text">IM-administered influenza vaccines should be administered by needle and syringe only, with the exception of the MDV presentation of Afluria Quad rival ent, which may alternatively be given by the PharmaJet Strat is jet injector for persons age ¶</div>
<div class="text">that any influenza vaccine (egg based or non egg based) that is otherwise appropriate for the recipient sage and health status can be used (see Persons with a History of Egg Allergy). The approved dose volume for Afluria Quad rival ent is 0.25 mL for children aged 6 through 35 months and 0.5 mL for persons aged ≥3 years. However, 0.25-mL pre filled syringes are no longer available. For children aged 6 through 35 §</div>
<div class="text">Availability and characteristics of specific products and presentations might change or differ from what is described in this table and in the text of this report. Although a history of severe allergic reaction (e.g., anaphylaxis) to egg is a labeled contra indication to the use of egg based †</div>
<div class="text">* Manufacturer package inserts and updated CDC and ACIP guidance should be consulted for additional information concerning, but not limited to, indications, contra indications, warnings, and precautions. Package inserts for U.S.-licensed</div>
<div class="text">LAIV4 (egg based vaccine ) FluMist Quad rival ent (AstraZeneca) 0.2-mL pre filled single- use intra nasal sprayer 2 through 49 yrs 10 fluorescent focus units 0 2 mL NAS — Abbreviations: ACIP = Advisory Committee on Immunization Practices; HA = hemagglutinin; IIV4 = in activated influenza vaccine, quad rival ent; IM = intramuscular; LAIV4 = live attenuated influenza vaccine, quad rival ent; MDV = multi dose vial; PFS fill d RIV4 bfl d l SDV l d l 6 5 7 5</div>
<div class="title">(San of i Pasteur)</div>
<div class="title">Fluad Quad rival ent (Seqirus) 0.5-mL PFS ≥65 yrs 15 µg/0.5 mL IM — RIV4 (recombinant HA vaccine) ¶</div>
</div>
<div class="metadata">
<h3>Extraction Metadata</h3>
<p>Text blocks: 8</p>
<p>Figures/Tables: 3</p>
</div>

</body>
</html>
